CLINICAL_TRIALS ClinicalTrials.gov record update

Immunogenicity and Safety Study of GSK Biologicals' Quadrivalent Split Virion Influenza Vaccine 2014/2015 Influsplit™ Tetra (Fluarix™ Tetra) (GSK2321138A) When Co-administered With Pneumovax™ 23 in Adults 50 Years of Age and Older

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02218697
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:58.355445+00:00
Published At: 2017-03-09T00:00:00+00:00
Record Updated At: 2018-04-03
Results Posted At: 2017-03-09
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Influenza"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-04-03"
protocolSection.identificationModule.nctId: "NCT02218697"
protocolSection.identificationModule.officialTitle: "Immunogenicity and Safety Study of GSK Biologicals\u0027 Quadrivalent Split Virion Influenza Vaccine 2014/2015 Influsplit\u2122 Tetra (Fluarix\u2122 Tetra) (GSK2321138A) When Co-administered With Pneumovax\u2122 23 in Adults 50 Years of Age and Older"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-03-09"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.